Sagimet Biosciences Inc Series A Common Stock
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -11,925 | -19,865 | -16,201 | -16,902 |
EBIT | -11,925 | -19,865 | -18,195 | -16,902 |
Net Income | -10,386 | -18,176 | -16,201 | -14,619 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -9,101 | -14,536 | -11,024 | -19,569 |
Cash | 42,327 | 64,717 | 75,840 | 77,014 |
Basic Shares | 32,195 | 32,195 | 32,195 | 32,143 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $2,000 | $0 | $0 |
Gross Profit | 2,000 | -130 | -134 | |
EBITDA | -45,567 | -30,740 | -31,055 | -23,719 |
EBIT | -54,454 | -61,484 | -31,055 | -23,719 |
Net Income | -45,567 | -27,876 | -30,499 | -24,442 |
Net Change In Cash | 0 | 2,000 | 0 | 0 |
Free Cash Flow | -42,435 | -23,766 | -24,490 | -21,710 |
Cash | 75,840 | 75,139 | 158 | 56,731 |
Basic Shares | 31,350 | 18,194 | 22,174 | 22,174 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.32 |
2025-03-31 | -$0.56 |
2024-12-31 | -$0.50 |
